We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FERG:NYSEFerguson Enterprises Inc. Analysis

Data as of 2026-08-31 - not real-time

$228.49

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Ferguson Enterprises Inc. is neutral at $228.49, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 1.5%. Relative strength is 38.9 — approaching oversold — and the MACD signal is bearish. The recent range runs from support at $227.92 up to resistance at $267.84.
On valuation the read is fair — earnings multiple of 22.5 versus a 29.4 sector average, below the peer group. Analyst price targets sit 26.1% above the current price. Revenue is growing at 4.6% on a 6.3% profit margin. The 1.53% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 34.3%, a beta of 1.20 and a maximum drawdown of 18.6%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

<?xml encoding="utf-8" ? Ferguson Enterprises Inc. FERG stock traded higher Monday after the company reported...Ferguson lifted full-year sales growth guidance to mid-single digit as non-residential revenue grew 8% on large capital...Shares of distributor Ferguson Enterprises Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 240.25
  • MACD momentum is negative
  • RSI at 38.9 is in neutral territory

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 22.5 versus sector average of 29.4
  • Trading below the 200-day average of 240.25
  • Analyst targets imply +26.1% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 22.5 versus sector average of 29.4
  • Analyst targets imply +26.1% versus the current price
  • Dividend yield of 1.53%

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin6.32%
P/E Ratio22.5
Debt/Equity111.06
P/B Ratio7.1
Op. Cash Flow$1.7B
Industry P/E29.4

Technical Analysis

TrendNeutral
RSI38.9
Support$227.92
Resistance$267.84
MA 20$245.27
MA 50$237.08
MA 200$240.25
MACDBearish
VolumeDecreasing
Fear & Greed Index95.66

Valuation

Fair Value$60.24
Target Price$288.10
Upside/Downside26.09%
GradeFair
TypeBlend
Dividend Yield1.53%

Risk Assessment

Beta1.20
Volatility34.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.